Okay, let's tackle this question. The question is asking about which thyroid cancer is associated with an amyloid stroma. First, I need to recall the different types of thyroid cancers and their histological features.

Thyroid cancers include papillary, follicular, medullary, and anaplastic. Medullary thyroid carcinoma (MTC) is known for producing calcitonin. Amyloid stroma is a key feature here. I remember that amyloid is an extracellular protein deposit. In MTC, the amyloid is derived from calcitonin, which is produced in excess by the cancerous C cells. So the amyloid in MTC is calcitonin-derived.

Now, checking the other options. Papillary thyroid carcinoma has psammoma bodies and papillary architecture. Follicular has follicles with colloid. Anaplastic is undifferentiated and aggressive. None of these have amyloid. So the correct answer should be medullary thyroid carcinoma. The wrong options don't have amyloid stroma. The clinical pearl is that MTC's amyloid is calcitonin-related, and it's linked to multiple endocrine neoplasia (MEN) 2 syndromes. Need to make sure the explanation covers the mechanism and why others are wrong.

**Core Concept**
Amyloid stroma in thyroid cancer is a histopathological hallmark of **medullary thyroid carcinoma (MTC)**, arising from parafollicular C cells. The amyloid is composed of **calcitonin**, a hormone overproduced by these neoplastic cells. This feature differentiates MTC from other thyroid malignancies.

**Why the Correct Answer is Right**
Medullary thyroid carcinoma originates from **C cells** (parafollicular cells) that synthesize calcitonin. Tumor cells secrete large amounts of calcitonin, which accumulates as **amyloid fibrils** in the stroma. These amyloid deposits are Congo red-positive and apple-green birefringent under polarized light. MTC is also associated with **multiple endocrine neoplasia (MEN) 2 syndromes** due to RET proto-oncogene mutations.

**Why Each Wrong Option is Incorrect**
**Option A:** *Papillary thyroid carcinoma* features **psammoma bodies** and papillary architecture, not amyloid.
**Option B:** *Follicular thyroid carcinoma* exhibits **follicular structures** with colloid, lacking amyloid.
**Option C:** *Anaplastic thyroid carcinoma* is undifferentiated and aggressive, with no amyloid stroma.

**Clinical Pearl / High-Yield Fact**
Remember: **Amyloid + calcitonin = MTC**. Always associate MTC with **C-cell origin**, **amyloid stroma**, and **MEN 2**. This is a classic exam trap—students often confuse MTC with other thyroid cancers due to overlapping features.

**Correct Answer: C. Medullary thyroid carcinoma**

✓ Correct Answer: B. Medullary Ca